ARCHIVES

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Reagan Family History Shows String Risk Factor

August 2, 1985

Prevention Clinical Trials Heads Greenwalk Priority Lists For ‘86

February 8, 1985

New Food Technology Could Lower Cancer Risk, Greenwald Says; Nutrition Lab Needed

January 27, 1989

Columbus CCP Forms New Entity to Administer CCOP

July 20, 1990

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

Organ Systems Program Reorganization Complete; Annual Conferences To Replace Working Groups

May 26, 1989